Pfizer’s COVID-19 vaccine is less effective for young children than it is for teenagers and adults, according to a new study.
New York State Health Officer discovered that two doses of the drug provides minimal protection against infection for children 5 to 11 years of age approximately one month after full immunization.
“In the Omicron era, effective against cases [the Pfizer-BioNTech vaccine] The study’s authors wrote: the decline is rapid for children, especially those 5-11 years old.
Pfizer vaccine is the only COVID-19 vaccine available today Federally approved for children ages 5 to 11.
However, research – performed at the peak of the Omicron . variation increase in December and January – found that the vaccine provided significant protection against severe disease.
“Immunization of children aged 5-11 years is a protective measure against serious diseases and is encouraged,” the authors said.
But the report also suggests that pediatric dosing regimens should be revisited because the results are so low.
Younger children now receive a third of the dose of Pfizer that is given to older adolescents and adults.
Researchers surveyed 865,000 cases of coronavirus for children aged 5 to 11 years old and 365,000 cases for people 12 to 17 years old.
For the younger group, resistance to infection decreased from 68% to 12% one month after full vaccination.
For 12- to 17-year-olds, the drop went from 66% to 51%, according to the study.
Hospitalization protection rates for the younger group fell from 100 to 48 percent one month after vaccination, compared with a reduction of 85 to 73 percent for the 12- to 17-year-old group.
The study comes just days after the New York City Department of Education reported that only 52 percent of children in the nation’s largest school system are fully immunized against the coronavirus.
Both Governor Kathy Hochul and Mayor Eric Adams suggested that they would support Vaccination mission for all city students At a few points.
https://nypost.com/2022/02/28/ny-study-pfizer-vax-far-less-effective-in-younger-kids/ Pfizer vax less effective in young children